FR2057296A5 - Stabiliser for colloidal solution - Google Patents
Stabiliser for colloidal solutionInfo
- Publication number
- FR2057296A5 FR2057296A5 FR6927512A FR6927512A FR2057296A5 FR 2057296 A5 FR2057296 A5 FR 2057296A5 FR 6927512 A FR6927512 A FR 6927512A FR 6927512 A FR6927512 A FR 6927512A FR 2057296 A5 FR2057296 A5 FR 2057296A5
- Authority
- FR
- France
- Prior art keywords
- stabiliser
- colloidal solution
- gelatine
- modified
- wts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0034—Additives, e.g. in view of promoting stabilisation or peptisation
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09H—PREPARATION OF GLUE OR GELATINE
- C09H5/00—Stabilisation of solutions of glue or gelatine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Colloid Chemistry (AREA)
Abstract
Stabiliser for e.g. medicinal and radioactive colloidal solns., consists of a modified gelatine containing fractions with mol. wts. 20,000 (23 - 27 wt.%); 10,000 (45 - 55 wt.%), the remainder being 10,000. The modified gelatine may be obtained by the action of water at 1.1 - 1.3 atm. and 125 - 135 degrees C on a mixture of gelatine, NaCl and succinic anhydride, neutralising and bacterial filtering.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR6927512A FR2057296A5 (en) | 1969-08-11 | 1969-08-11 | Stabiliser for colloidal solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR6927512A FR2057296A5 (en) | 1969-08-11 | 1969-08-11 | Stabiliser for colloidal solution |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2057296A5 true FR2057296A5 (en) | 1971-05-21 |
Family
ID=9038885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR6927512A Expired FR2057296A5 (en) | 1969-08-11 | 1969-08-11 | Stabiliser for colloidal solution |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2057296A5 (en) |
-
1969
- 1969-08-11 FR FR6927512A patent/FR2057296A5/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5272026A (en) | Air-to-fuel rate control system | |
JPS5394740A (en) | Microprogram control system | |
FR2057296A5 (en) | Stabiliser for colloidal solution | |
ES390305A1 (en) | Method of preparing sobrerol and the pharmaceutical application of the sobrerol thus obtained | |
GB1301555A (en) | ||
GB1149458A (en) | Stabilized chlorofluoroalkane compositions | |
CA945473A (en) | PROCESS FOR STABILIZATION OF A COMPOSITION OF 2.alpha.,3.alpha.-EPITHIO-ANDROSTANES AND COMPOSITION OBTAINED THEREBY | |
CH375371A (en) | Process for the preparation of acyl derivatives of 2-methyl-5-oxy-8- (B-diethylamino-ethoxy) -furo- (2 ', 3': 6.7) -chromone | |
AT311564B (en) | Process for the preparation of new 6,11β-dichloro-19-norsteroid-4-en (or 4,6-diene) -3-ones unsubstituted in the 9α-position | |
GB1140543A (en) | Steroid cycloborate complexes | |
SU193080A1 (en) | ||
JPS51126798A (en) | Ultrasonic alarming unit | |
GB1050312A (en) | ||
GB1232093A (en) | ||
GB1182237A (en) | A Process for Ion-Exchange in Liquids. | |
JPS5224043A (en) | Series display unit of electronic computer | |
YY | Medic | |
FR1353512A (en) | Inhibition of the corrosive action of water of low hardness | |
Synge | The Natural Philosophy of Time | |
Teeters | Alexander Maconochie of Norfolk Island | |
Chaudhary | Cross-reaction studies within the picornavirus group by immunofluorescence and electron microscopy. | |
Morton | " The Investor Capitalization Theory of the Cost of Equity Capital": Rejoinder | |
Katayama | Advertising in Japan, 1947-1959, as influenced by the social and economic changes in the postwar period | |
Appleyard | Improvements to the language and implementation of APL | |
GB1130867A (en) | The preparation of optically active -‡-methyl--‡-amino--ß-(hydroxyphenyl)propionic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |